I suggest you make mistakes by asking questions about ValiMed on a stock chat board. Your questions and concerns can best be answered by those that work with it directly.
If you would like to know about the earlier version of ValiMed stopping diversion, consider James Jorgenson.
For the 18-month peer reviewed ValiMed Study, consider trying Yaman Kaakeh, Pharm.D. That study is also available via US National Library of Medicine National Institutes of Health
A tabletop EPS device demonstrated acceptable sensitivity and specificity for validating the identity and concentrations of selected high-risk i.v. medications compounded for pediatric patients. The device may help prevent clinically important medication errors caused by inaccurate compounding.
Her winning article, “Enhanced Photoemission Spectroscopy for Verification of High-Risk I.V. Medications,” was co-authored with Hanna Phan, Pharm.D., Brian D. DeSmet, Pharm.D., M.S., Deborah A. Pasko, Pharm.D., Denise K. Glenn, B.S.Pharm., and James G. Stevenson, Pharm.D., FASHP. The article was published in the American Journal of Health-System Pharmacy. ....
To contact the company, ask for a visit... (I would strongly suggest asking when and where the ValiMed G4 is being demonstrated the remaining portion of this year, or consider visiting their location).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.